Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (81-90 of 250) with videos related to

Pageof 25
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2026
Staging of Lung Cancer: A Call for Developing Uniform and Universal Key Performance Indicators and Benchmarks to Elevate Clinical StandardsJan P Van Meerbeeck, Jelle E Bousema, Wen Wen, et al.
Translational Lung Cancer Research|November 20, 2018
Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendationsCharlotte De Bondt, Ioannis Psallidas, Paul E Y Van Schil, et al.
Lung Cancer (Amsterdam, Netherlands)|April 13, 2011
Quantitative Perfusion Scintigraphy or Anatomic Segment Method in lung cancer resectionTom Holvoet, Jan P van Meerbeeck, Christophe Van De Wiele, et al.
Frontiers in Oncology|June 6, 2012
Investigational approaches for mesotheliomaVeerle F Surmont, Eric R E van Thiel, Karim Vermaelen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 24, 2007
FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levelsChristophe Van de Wiele, Frédéric VandeVyver, Caroline Debruyne, et al.
The Oncologist|July 1, 2008
Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: present status and future prospectsJan P van Meerbeeck, Sabine Meersschout, Rebecca De Pauw, et al.
The European Respiratory Journal|March 2, 2016
Practical tools for implementing early palliative care in advanced lung cancerAnnelies Janssens, Liesbeth Teugels, Sisca Kohl, et al.
The European Respiratory Journal|April 18, 2020
Cancer in the time of COVID-19: expert opinion on how to adapt current practiceJo Raskin, Marnix Lebeer, Charlotte De Bondt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer GroupJulie Francart, Catherine Legrand, Richard Sylvester, et al.
The European Respiratory Journal|December 23, 2017
Exhaled breath to screen for malignant pleural mesothelioma: a validation studyKevin Lamote, Matthijs Vynck, Olivier Thas, et al.
Pageof 25

Showing results (81-90 of 250) with videos related to

Sort By:
Pageof 25
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2026
Staging of Lung Cancer: A Call for Developing Uniform and Universal Key Performance Indicators and Benchmarks to Elevate Clinical StandardsJan P Van Meerbeeck, Jelle E Bousema, Wen Wen, et al.
Translational Lung Cancer Research|November 20, 2018
Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendationsCharlotte De Bondt, Ioannis Psallidas, Paul E Y Van Schil, et al.
Lung Cancer (Amsterdam, Netherlands)|April 13, 2011
Quantitative Perfusion Scintigraphy or Anatomic Segment Method in lung cancer resectionTom Holvoet, Jan P van Meerbeeck, Christophe Van De Wiele, et al.
Frontiers in Oncology|June 6, 2012
Investigational approaches for mesotheliomaVeerle F Surmont, Eric R E van Thiel, Karim Vermaelen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 24, 2007
FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levelsChristophe Van de Wiele, Frédéric VandeVyver, Caroline Debruyne, et al.
The Oncologist|July 1, 2008
Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: present status and future prospectsJan P van Meerbeeck, Sabine Meersschout, Rebecca De Pauw, et al.
The European Respiratory Journal|March 2, 2016
Practical tools for implementing early palliative care in advanced lung cancerAnnelies Janssens, Liesbeth Teugels, Sisca Kohl, et al.
The European Respiratory Journal|April 18, 2020
Cancer in the time of COVID-19: expert opinion on how to adapt current practiceJo Raskin, Marnix Lebeer, Charlotte De Bondt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer GroupJulie Francart, Catherine Legrand, Richard Sylvester, et al.
The European Respiratory Journal|December 23, 2017
Exhaled breath to screen for malignant pleural mesothelioma: a validation studyKevin Lamote, Matthijs Vynck, Olivier Thas, et al.
Pageof 25